Pathology reporting of neuroendocrine tumors: Essential elements for accurate diagnosis, classification, and staging

Seminars in Oncology

Volumn 40, Issue 1, 2013, Pages 23-36

  Klimstra, David S ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD44V ANTIGEN; CD99 ANTIGEN; CORTICOTROPIN; CYTOKERATIN 19; EVEROLIMUS; GASTRIN; KI 67 ANTIGEN; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROGESTERONE RECEPTOR; PROTEIN P27; SOMATOSTATIN RECEPTOR; STEM CELL FACTOR RECEPTOR; TEMOZOLOMIDE; TRANSCRIPTION FACTOR CDX2; VASCULOTROPIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; CANCER CELL; CANCER CLASSIFICATION; CANCER GRADING; CANCER INVASION; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CARCINOID; CELL PROLIFERATION; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DNA METHYLATION; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; GASTROINTESTINAL TRACT; GENE MUTATION; GOLD STANDARD; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL NEUROENDOCRINE CARCINOMA; LIVER METASTASIS; LYMPH NODE METASTASIS; MEDICAL SOCIETY; NEUROENDOCRINE TUMOR; OUTCOME ASSESSMENT; PANCREAS; PRIORITY JOURNAL; PROTEIN DEPLETION; RISK ASSESSMENT; SMALL CELL CARCINOMA; SWEAT GLAND CARCINOMA; TUMOR NODE METASTASIS; UNITED STATES; WORLD HEALTH ORGANIZATION;

GASTROINTESTINAL TRACT; HUMANS; NEOPLASM STAGING; NEUROENDOCRINE TUMORS; PANCREAS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84873339539     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2012.11.001     Document Type: Article

References (112)

1. I.M. Modlin, M.D. Shapiro, M. Kidd Siegfried oberndorfer and the evolution of carcinoid disease Arch Surg 142 2007 187 197
2. C. Capella, E. Solcia, L.H. Sobin Endocrine tumours of the stomach S.R. Hamilton, L.A. Aaltonen, Pathology and genetics of tumours of the digestive system 2000 IARC Press Lyon 53 57
3. C. Capella, E. Solcia, L.H. Sobin Endocrine tumours of the small intestine S.R. Hamilton, L.A. Aaltonen, Pathology and genetics of tumours of the digestive system 2000 IARC Press Lyon 77 82
4. C. Capella, E. Solcia, L.H. Sobin Endocrine tumours of the colon and rectum S.R. Hamilton, L.A. Aaltonen, Pathology and genetics of tumours of the digestive system 2000 IARC Press Lyon 137 139
5. P.U. Heitz, P. Komminoth, A. Perren Pancreatic endocrine tumours: introduction R.A. DeLellis, R.V. Lloyd, P.U. Heitz, C. Eng, Pathology and genetics of tumours of endocrine organs 2004 IARC Press Lyon 177 182
6. C.S. Landry, C. Woodall, C.R. Scoggins Analysis of 900 appendiceal carcinoid tumors for a proposed predictive staging system Arch Surg 143 2008 664 670
7. A.N. Koura, G.G. Giacco, S.A. Curley Carcinoid tumors of the rectum: effect of size, histopathology, and surgical treatment on metastasis free survival Cancer 79 1997 1294 1298
8. S.N. Hochwald, S. Zee, K.C. Conlon Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups J Clin Oncol 20 2002 2633 2642
9. J. Leja, A. Essaghir, M. Essand Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas Mod Pathol 22 2009 261 272
10. G.C. Nikou, N.J. Lygidakis, C. Toubanakis Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues Hepatogastroenterology 52 2005 731 741
11. C. Bordi, T. D'Adda, C. Azzoni Criteria for malignancy in gastrointestinal endocrine tumors Endocr Pathol 17 2006 119 129
12. N. Sen, N. Calli Demirkan, A. Aksoy Altinboga Synchronous endocrine tumors of small intestine: report of a case Turk J Gastroenterol 19 2008 193 196
13. D.S. Klimstra, I.R. Modlin, N.V. Adsay Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set Am J Surg Pathol 34 2010 300 313
14. S.B. Edge, D.R. Byrd, M.A. Carducci AJCC cancer staging manual 7th ed. 2010 Springer New York
15. G. Rindi, G. Kloppel, H. Alhman TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system Virchows Arch 449 2006 395 401
16. B.N. Fahy, L.H. Tang, D. Klimstra Carcinoid of the rectum risk stratification (CaRRS): a strategy for preoperative outcome assessment Ann Surg Oncol 14 2007 396 404
17. C.S. Landry, G. Brock, C.R. Scoggins A proposed staging system for gastric carcinoid tumors based on an analysis of 1,543 patients Ann Surg Oncol 16 2009 51 60
18. G. Kloppel, A. Perren, P.U. Heitz The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification Ann N Y Acad Sci 1014 2004 13 27
19. G. Rindi, G. Kloppel, A. Couvelard TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system Virchows Arch 451 2007 757 762
20. D.S. Klimstra, I.R. Modlin, D. Coppola The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems Pancreas 39 2010 707 712
21. G. Rindi, R. Arnold, F.T. Bosman Nomenclature and classification of neuroendocrine neoplasms of the digestive system F.T. Bosman, F. Carneiro, R.H. Hruban, WHO classification of tumours of the digestive system 2010 IARC Press Lyon 13 14
22. M.K. Washington, L.H. Tang, J. Berlin Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the stomach Arch Pathol Lab Med 134 2010 187 191
23. M.K. Washington, L.H. Tang, J. Berlin Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the small intestine and ampulla Arch Pathol Lab Med 134 2010 181 186
24. M.K. Washington, L.H. Tang, J. Berlin Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the colon and rectum Arch Pathol Lab Med 134 2010 176 180
25. M.K. Washington, L.H. Tang, J. Berlin Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the appendix Arch Pathol Lab Med 134 2010 171 175
26. D. Klimstra, A. Perren, K. Oberg Pancreatic endocrine tumours: non-functioning tumours and microadenomas R.A. DeLellis, R.V. Lloyd, P.U. Heitz, C. Eng, Pathology and genetics of tumours of endocrine organs 2004 IARC Press Lyon 201 204
27. A. Ahmed, G. Turner, B. King Midgut neuroendocrine tumours with liver metastases Results of the UKINETS study Endocr Relat Cancer 16 2009 885 894
28. U.F. Pape, U. Berndt, J. Muller-Nordhorn Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours Endocr Relat Cancer 15 2008 1083 1097
29. F. Panzuto, S. Nasoni, M. Falconi Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization Endocr Relat Cancer 12 2005 1083 1092
30. M.R. Wick, F.M. Graeme-Cook Pancreatic neuroendocrine neoplasms: a current summary of diagnostic, prognostic, and differential diagnostic information Am J Clin Pathol 115 Suppl 2001 S28 S45
31. M.B. Beasley, F.B. Thunnissen, E. Brambilla Pulmonary atypical carcinoid: predictors of survival in 106 cases Hum Pathol 31 2000 1255 1265
32. M. Jamali, R. Chetty Predicting prognosis in gastroentero-pancreatic neuroendocrine tumors: an overview and the value of ki-67 immunostaining Endocr Pathol 19 2008 282 288
33. J.C. Yao, P.M. Hoff Molecular targeted therapy for neuroendocrine tumors Hematol Oncol Clin North Am 21 2007 575 581
34. M.H. Kulke New developments in the treatment of gastrointestinal neuroendocrine tumors Curr Oncol Rep 9 2007 177 183
35. K. Oberg, S. Jelic Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up Ann Oncol 19 Suppl 2 2008 ii104 ii105
36. R. Chetty Requiem for the term 'carcinoid tumour' in the gastrointestinal tract? Can J Gastroenterol 22 2008 357 358
37. J. Soga The term "carcinoid" is a misnomer: the evidence based on local invasion J Exp Clin Cancer Res 28 2009 15
38. W.D. Travis The concept of pulmonary neuroendocrine tumours W.D. Travis, E. Brambilla, H.K. Muller-Hermelink, C.C. Harris, Pathology and genetics of tumours of the lung, pleura, thymus and heart 2004 IARC Press Lyon 19 20
39. S. Suster, C.A. Moran Neuroendocrine neoplasms of the mediastinum Am J Clin Pathol 115 Suppl 2001 S17 S27
40. K. Tsuta, I.I. Wistuba, C.A. Moran Differential expression of somatostatin receptors 1-5 in neuroendocrine carcinoma of the lung Pathol Res Pract 208 2012 470 474
41. K. Tsuta, D.C. Liu, N. Kalhor Using the mitosis-specific marker anti-phosphohistone H3 to assess mitosis in pulmonary neuroendocrine carcinomas Am J Clin Pathol 136 2011 252 259
42. S. Yachida, E. Vakiani, C.M. White Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors Am J Surg Pathol 36 2012 173 184
43. J. Fontaine, N.M. Le Douarin Analysis of endoderm formation in the avian blastoderm by the use of quail-chick chimaeras The problem of the neurectodermal origin of the cells of the APUD series J Embryol Exp Morphol 41 1977 209 222
44. J. Rosai The origin of neuroendocrine tumors and the neural crest saga Mod Pathol 24 Suppl 2 2011 S53 S57
45. R. Arnold Endocrine tumours of the gastrointestinal tract Introduction: definition, historical aspects, classification, staging, prognosis and therapeutic options Best Pract Res Clin Gastroenterol 19 2005 491 505
46. G. Kloppel, M. Anlauf Epidemiology, tumour biology and histopathological classification of neuroendocrine tumours of the gastrointestinal tract Best Pract Res Clin Gastroenterol 19 2005 507 517
47. G. Kloppel, M. Anlauf, A. Perren Endocrine precursor lesions of gastroenteropancreatic neuroendocrine tumors Endocr Pathol 18 2007 150 155
48. E. Solcia, R. Fiocca, L. Villani Hyperplastic, dysplastic, and neoplastic enterochromaffin-like-cell proliferations of the gastric mucosa Classification and histogenesis Am J Surg Pathol 19 Suppl 1 1995 S1 S7
49. E. Vilar, R. Salazar, J. Perez-Garcia Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors Endocr Relat Cancer 14 2007 221 232
50. U. Plockinger, G. Rindi, R. Arnold Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS) Neuroendocrinology 80 2004 394 424
51. G. Kloppel, G. Rindi, M. Anlauf Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors Virchows Arch 451 Suppl 1 2007 S9 S27
52. W.D. Travis, W. Rush, D.B. Flieder Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid Am J Surg Pathol 22 1998 934 944
53. H. Nassar, J. Albores-Saavedra, D.S. Klimstra High-grade neuroendocrine carcinoma of the ampulla of vater: a clinicopathologic and immunohistochemical analysis of 14 cases Am J Surg Pathol 29 2005 588 594
54. C.M. Fenoglio-Preiser Gastrointestinal neuroendocrine/neuroectodermal tumors Am J Clin Pathol 115 Suppl 2001 S79 S93
55. C.S. Cho, D.M. Labow, L. Tang Histologic grade is correlated with outcome after resection of hepatic neuroendocrine neoplasms Cancer 113 2008 126 134
56. A. Couvelard, L. Deschamps, P. Ravaud Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumors Mod Pathol 22 2009 273 281
57. A. Perren, J. Roth, S. Muletta-Feurer Clonal analysis of sporadic pancreatic endocrine tumours J Pathol 186 1998 363 371
58. J. Zhao, H. Moch, A.F. Scheidweiler Genomic imbalances in the progression of endocrine pancreatic tumors Genes Chromosomes Cancer 32 2001 364 372
59. S. Kytola, A. Hoog, B. Nord Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids Am J Pathol 158 2001 1803 1808
60. I.M. Modlin, M. Kidd, I. Latich Current status of gastrointestinal carcinoids Gastroenterology 128 2005 1717 1751
61. Z. Yang, L.H. Tang, D.S. Klimstra Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification Am J Surg Pathol 35 2011 853 860
62. Z. Yang, L.H. Tang, D.S. Klimstra How many needle core biopsies are needed to comfortably predict the histologic grade of metastatic well differentiated neuroendocrine tumors to the liver? Mod Pathol 25 2012 426A
63. L.H. Tang, M. Gonen, C. Hedvat et al. Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods Am J Surg Pathol 36 2012 1761 1770
64. D. Dhall, D.P. Frishberg, G. Galliano Interobserver variability in assessing Ki67 proliferative index in gastrointestinal well-differentiated neuroendocrine neoplasms Mod Pathol 22 2009 116A
65. M. Lejeune, J. Jaen, L. Pons Quantification of diverse subcellular immunohistochemical markers with clinicobiological relevancies: validation of a new computer-Assisted image analysis procedure J Anat 212 2008 868 878
66. C.M. McCall, C. Shi, T. Ellison Ki-67 Proliferation index and mitotic rate discordance in pancreatic neuroendocrine tumors correlates with aggressive histologic features and decreased overall survival Mod Pathol 25 2012 446A 447A
67. L. Tang, J. Shia, E. Vakiani High grade transformation of differentiated neuroendocrine neoplasms (NENs) of the enteropancreatic system - a unique entity distinct from de novo high grade neuroendocrine carcinoma (HGNECa) in pathogenesis and clinical behavior Mod Pathol 21 2008 137A
68. H. Sorbye, S. Welin, S.W. Langer Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal poorly differentiated neuroendocrine carcinoma: the NORDIC NEC study J Clin Oncol 30 suppl 2012
69. F.L. Green, D.L. Page, I.D. Fleming AJCC cancer staging manual 6th ed. 2002 Springer New York
70. J.C. Yao, M. Hassan, A. Phan One hundred years after " carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States J Clin Oncol 26 2008 3063 3072
71. G. Kloppel, G. Rindi, A. Perren The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement Virchows Arch 456 2010 595 597
72. Dolcetta-Capuzzo A, Villa V, Albarello L, et al. Gastroenteric neuroendocrine neoplasms classification: Comparison of prognostic models. Cancer. In press.
73. G. Rindi, M. Falconi, C. Klersy TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study J Natl Cancer Inst 104 2012 764 777
74. M.P. Hoang, R.H. Hruban, J. Albores-Saavedra Clear cell endocrine pancreatic tumor mimicking renal cell carcinoma: a distinctive neoplasm of von Hippel-Lindau disease Am J Surg Pathol 25 2001 602 609
75. R.V. Lloyd Practical markers used in the diagnosis of neuroendocrine tumors Endocr Pathol 14 2003 293 301
76. S. La Rosa, E. Rigoli, S. Uccella Prognostic and biological significance of cytokeratin 19 in pancreatic endocrine tumours Histopathology 50 2007 597 606
77. A. Ali, S. Serra, S.L. Asa The predictive value of CK19 and CD99 in pancreatic endocrine tumors Am J Surg Pathol 30 2006 1588 1594
78. A. Goto, T. Niki, Y. Terado Prevalence of CD99 protein expression in pancreatic endocrine tumours (PETs) Histopathology 45 2004 384 392
79. A. Chaudhry, A. Gobl, B. Eriksson Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors Cancer Res 54 1994 981 986
80. A. Rahman, A. Maitra, R. Ashfaq Loss of p27 nuclear expression in a prognostically favorable subset of well-differentiated pancreatic endocrine neoplasms Am J Clin Pathol 120 2003 685 690
81. G. Pelosi, E. Bresaola, G. Bogina Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: a comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variables Hum Pathol 27 1996 1124 1134
82. M. Krausch, A. Raffel, M. Anlauf Loss of PTEN expression in neuroendocrine pancreatic tumors Horm Metab Res 43 2011 865 871
83. V. Deshpande, C. Fernandez-del Castillo, A. Muzikansky Cytokeratin 19 is a powerful predictor of survival in pancreatic endocrine tumors Am J Surg Pathol 28 2004 1145 1153
84. Z. Yang, L.H. Tang, D.S. Klimstra Evaluation of prognostic markers in metastatic well-differentiated neuroendocrine tumors to the liver Mod Pathol 25 2012 426A
85. A.T. Phan, J.C. Yao, D.B. Evans Treatment options for metastatic neuroendocrine tumors Surgery 144 2008 895 898
86. I.M. Jaffee, M. Rahmani, M.G. Singhal Expression of the intestinal transcription factor CDX2 in carcinoid tumors is a marker of midgut origin Arch Pathol Lab Med 130 2006 1522 1526
87. A. Saqi, D. Alexis, F. Remotti Usefulness of CDX2 and TTF-1 in differentiating gastrointestinal from pulmonary carcinoids Am J Clin Pathol 123 2005 394 404
88. A. Srivastava, J.L. Hornick Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors Am J Surg Pathol 33 2009 626 632
89. A.M. Schmitt, F. Riniker, M. Anlauf Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases Am J Surg Pathol 32 2008 420 425
90. J. Lu, L.Y. Xue, N. Lu Superficial primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical analysis of 15 cases Dis Esophagus 23 2010 153 159
91. W. Wang, J.I. Epstein Small cell carcinoma of the prostate A morphologic and immunohistochemical study of 95 cases Am J Surg Pathol 32 2008 65 71
92. J. Shia, L.H. Tang, M.R. Weiser Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity? Am J Surg Pathol 32 2008 719 731
93. W. Cheuk, M.Y. Kwan, S. Suster Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from Merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas Arch Pathol Lab Med 125 2001 228 231
94. G. Hermann, B. Konukiewitz, A. Schmitt Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2 Virchows Arch 459 2011 147 154
95. J. Koo, R.B. Mertens, J.M. Mirocha Value of Islet 1 and PAX8 in identifying metastatic neuroendocrine tumors of pancreatic origin Mod Pathol 25 2012 893 901
96. I.M. Modlin, K. Oberg, D.C. Chung Gastroenteropancreatic neuroendocrine tumours Lancet Oncol 9 2008 61 72
97. K. Oberg Somatostatin analog octreotide LAR in gastro-entero-pancreatic tumors Expert Rev Anticancer Ther 9 2009 557 566
98. U. Plockinger, B. Wiedenmann Neuroendocrine tumors Biotherapy Best Pract Res Clin Endocrinol Metab 21 2007 145 162
99. M. Van Essen, E.P. Krenning, M. De Jong Peptide receptor radionuclide therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours Acta Oncol 46 2007 723 734
100. D. Granberg Investigational drugs for neuroendocrine tumours Expert Opin Investig Drugs 18 2009 601 608
101. M.H. Kulke, J.L. Hornick, C. Frauenhoffer O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors Clin Cancer Res 15 2009 338 345
102. I.M. Modlin, M. Kidd, I. Drozdov Pharmacotherapy of neuroendocrine cancers Expert Opin Pharmacother 9 2008 2617 2626
103. E.T. Janson Somatostatin analogs in the treatment of neuroendocrine gastroenteropancreatic and intrathoracic tumors J Endocrinol Invest 28 2005 137 140
104. J.C. Yao Neuroendocrine tumors Molecular targeted therapy for carcinoid and islet-cell carcinoma Best Pract Res Clin Endocrinol Metab 21 2007 163 172
105. J.C. Yao, A.T. Phan, D.Z. Chang Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study J Clin Oncol 26 2008 4311 4318
106. D.L. Reidy, L.H. Tang, L.B. Saltz Treatment of advanced disease in patients with well-differentiated neuroendocrine tumors Nat Clin Pract Oncol 6 2009 143 152
107. K. Oberg, B. Eriksson Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours Best Pract Res Clin Endocrinol Metab 19 2005 265 276
108. M. Perigny, P. Hammel, O. Corcos Pancreatic endocrine microadenomatosis in patients with von Hippel-Lindau disease: characterization by VHL/HIF pathway proteins expression Am J Surg Pathol 33 2009 739 748
109. M. Anlauf, A. Perren, G. Kloppel Endocrine precursor lesions and microadenomas of the duodenum and pancreas with and without MEN1: criteria, molecular concepts and clinical significance Pathobiology 74 2007 279 284
110. M. Anlauf, R. Schlenger, A. Perren Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome Am J Surg Pathol 30 2006 560 574
111. O. Lin, S. Olgac, I. Green Immunohistochemical staining of cytologic smears with MIB-1 helps distinguish low-grade from high-grade neuroendocrine neoplasms Am J Clin Pathol 120 2003 209 216
112. G. Pelosi, J. Rodriguez, G. Viale Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients Am J Surg Pathol 29 2005 179 187